AEMDAethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address un…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Aethlon Medical, Inc. Q1 2027 Earnings Call Summary Moby summary of Aethlon Medical, Inc.'s Q1 2027 earnings call | ||
PProactive | ||
 Aethlon Medical, Inc. Q4 2026 Earnings Call Summary Moby summary of Aethlon Medical, Inc.'s Q4 2026 earnings call | ||
Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ... Aethlon Medical Inc (AEMD) reports significant strides in oncology trials and research platform expansion, despite facing increased operating expenses. | ||
 Aethlon Medical, Inc. Q3 2026 Earnings Call Summary Moby summary of Aethlon Medical, Inc.'s Q3 2026 earnings call | ||
 Aethlon Medical announces pricing of $4.5M common stock, warrant offering Aethlon Medical (AEMD) announced the pricing of a public offering of an aggregate of 5M shares of its common stock and warrants to purchase up to 5M shares of common stock at a combined public offering price of 90c per share and accompanying warrant. The warrants will have an exercise price of 90c per share, will be exercisable immediately upon issuance and will expire on the fifth anniversary of the original issuance date. The closing of the offering is expected to occur on or about September 5 | ||